Raul R. Rodriguez

2017

In 2017, Raul R. Rodriguez earned a total compensation of $2.2M as President and Chief Executive Officer at Rigel Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$370,800
Option Awards$1,180,636
Salary$618,000
Other$3,354
Total$2,172,789

Rodriguez received $1.2M in option awards, accounting for 54% of the total pay in 2017.

Rodriguez also received $370.8K in non-equity incentive plan, $618K in salary and $3.4K in other compensation.

Rankings

In 2017, Raul R. Rodriguez's compensation ranked 5,119th out of 14,666 executives tracked by ExecPay. In other words, Rodriguez earned more than 65.1% of executives.

ClassificationRankingPercentile
All
5,119
out of 14,666
65th
Division
Manufacturing
1,820
out of 5,772
69th
Major group
Chemicals And Allied Products
540
out of 2,075
74th
Industry group
Drugs
416
out of 1,731
76th
Industry
Pharmaceutical Preparations
329
out of 1,333
75th
Source: SEC filing on April 4, 2018.

Rodriguez's colleagues

We found five more compensation records of executives who worked with Raul R. Rodriguez at Rigel Pharmaceuticals in 2017.

2017

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2017

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

2017

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2017

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2017

Esteban Masuda

Rigel Pharmaceuticals

Executive Vice President, Research

News

In-depth

You may also like